Factory 99% Clopidogrel Bisulfate Powder CAS 120202-66-6 Chemical Intermediate

• Prevention of Cardiovascular Events Clopidogrel Bisulfate is primarily used to reduce the risk of myocardial infarction, stroke, and other atherosclerotic events in patients with established cardiovascular disease.
• Combination Therapy It is often prescribed in combination with aspirin for the management of acute coronary syndromes, including NSTEMI and unstable angina.
• Post-stenting Management Used following percutaneous coronary intervention (PCI) with stent placement to prevent stent thrombosis.

• Inhibition of Platelet Aggregation Selectively inhibits the binding of adenosine diphosphate (ADP) to its platelet receptor, inhibiting platelet aggregation.
• Antiplatelet Activity Irreversibly modifies the platelet, affecting its lifespan and reducing its ability to form blood clots.
• Improvement in Cardiovascular Outcomes Proven to reduce the incidence of myocardial infarction and stroke in at-risk patients.

Product Gallery